A brake pedal that turns out to be the engine

Every immune system needs a way to sense danger and hit the gas. In humans, that job largely falls to a protein called MAVS, which detects invading viruses and switches on the body's antiviral response. Researchers at Hebrew University of Jerusalem went looking for an ancient version of that same system in sea anemones, animals that split from the lineage leading to humans more than 600 million years ago. What they found broke the logic of the system entirely.

The study, published June 30 in Nature Ecology & Evolution, was led by PhD candidate Ton Sharoni and Professor Yehu Moran, working with collaborators at the University of North Carolina at Charlotte. The team identified a previously unknown protein in the sea anemone Nematostella vectensis, which they named CARDIB — short for CARD Inhibitor Binding protein. On paper, CARDIB looked like it should be MAVS's ancient cousin, structurally similar enough that researchers expected it to activate the same kind of antiviral alarm. It did the opposite.

An inhibitor that's somehow indispensable

Sharoni described the result plainly: everything about CARDIB suggested it should function like MAVS, according to Professor Moran's own account of the findings, yet the experiments told a different story. Under normal conditions, CARDIB acts as a brake on the immune system, suppressing the very antiviral pathway that MAVS is built to switch on in vertebrates. That alone would be a modestly interesting finding. What makes it strange is what happened when researchers took the brake away entirely.

Using CRISPR gene editing, the team removed the CARDIB gene from sea anemones and then exposed them to viral infection. Rather than becoming more resistant to the virus without their suppressive protein in the way, the anemones became significantly more vulnerable to infection. Sharoni called the outcome completely counterintuitive: a protein that dampens immune signaling under ordinary circumstances turns out to be essential when the animal actually needs to fight off a virus. Nature, evidently, built at least one immune system that runs the opposite direction from the model humans rely on, and still made it work.

Two branches of the same evolutionary tree, two different answers

The deeper implication here isn't really about sea anemones specifically — it's about how many times evolution has solved the "detect and fight a virus" problem, and whether it kept using the same toolkit each time. Sea anemones belong to the phylum Cnidaria, a group that also includes corals, jellyfish, and hydroids, all of which diverged from the animal lineage that eventually produced vertebrates more than 600 million years ago, back in the Precambrian eon. Because that split happened so early, any similarity between a sea anemone's immune machinery and a human's tells scientists something concrete about how ancient that machinery actually is.

The CARDIB findings complicate a working assumption that's been common in evolutionary immunology: that once a core defense mechanism evolves, it tends to get conserved and reused across descendant species with only minor tweaks. Here, a structurally similar protein family produced functionally opposite outcomes. That suggests, as the researchers describe it, that a single antiviral strategy did not persist uniformly throughout animal evolution. Different lineages appear to have taken structurally comparable starting material and built genuinely different molecular solutions to the same problem — suppression instead of activation, and yet somehow reaching the same practical goal of fending off infection.

Why the humble sea anemone keeps surprising immunologists

None of this would have been discoverable by studying humans, mice, or the other handful of lab organisms that dominate biomedical research. That's the quieter point buried in this study. Sea anemones aren't a popular model organism because they cure diseases or make good drug-testing subjects; they're useful precisely because they sit far enough back on the evolutionary tree to preserve solutions that vanished or got rebuilt differently in the vertebrate lineage. Every time researchers look closely at an organism this distant from humans, they risk finding a mechanism nobody predicted, simply because nobody had looked there before.

That's exactly what happened with CARDIB. The protein wasn't on anyone's radar as a research target until this project set out to trace MAVS's evolutionary ancestry and found something that looked like an ancestor but behaved like an inversion. It's a reminder that "ancient" doesn't mean "simple," and that assuming continuity between an ancestral protein and its modern descendant can lead researchers to overlook genuine divergence sitting in plain view.

What this could mean beyond the anemone tank

There's a practical dimension worth noting, even though the researchers were focused on basic evolutionary biology rather than therapeutics. Antiviral drug development in humans has largely been built around amplifying or mimicking MAVS-pathway activation. If nature has already demonstrated at least one alternative circuit — one where suppressing a signal, under the right conditions, produces a stronger antiviral outcome — that's a conceptual model worth understanding even if the sea anemone's exact molecular machinery doesn't translate directly to human biology.

For now, the finding stands mainly as a correction to how confidently biologists can extrapolate backward from complex organisms to their evolutionary origins. Humans and sea anemones both need protection from viruses, as the research team put it, but got there by fundamentally different molecular routes. Given how much of immunology research assumes shared ancestry implies shared mechanism, that's a more consequential finding than a single obscure marine protein might suggest at first glance.

*This article was researched using publicly available reporting from EurekAlert, ScienceDaily, phys.org, ecomagazine, and the peer-reviewed study published in Nature Ecology & Evolution. It is intended for informational purposes.*